COMPASS THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $3.85M.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $21.00K, a 320.00% increase year-over-year.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $41.00K.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $5.00K.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $1.27M.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $62.00K, a 313.33% increase from fiscal 2022.
- COMPASS THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $15.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $3.85M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $1.27M 10-K · filed 2026-03-05 | |
| 2023-12-31 | $62.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $21.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $41.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $15.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $5.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |